ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 654378 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 654378; 2) Community: the network communities that were significantly associated with the response to NSC 654378; 3) Molecule: the relationships between components within communities and NSC 654378; 4) MDR: the compounds that were significantly associated with the NSC 654378.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0385613993886001 0.28499446
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0385613993886001 0.19837058
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0385613993886001 0.26084413
NSC 267713 Digitoxigenin glycoside 0.0385613993886001 0.18634788
NSC 300289 Pinafide 0.0385613993886001 0.02267742
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0385613993886001 0.34181478
NSC 331935 CHALCONE ANALOG 0.0385613993886001 0.34116592
NSC 332488 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)- 0.0385613993886001 0.26032017
NSC 33570 Null 0.0385613993886001 0.43879373
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0385613993886001 0.27114577
Total:113  Current:80    [First] [Prev] [Next] [Last]